Companies: 11,241     total market cap: A$216.442 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Neurocrine Biosciences
NBIX
#1464
Rank
A$21.85 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
A$215.04
Share price
-1.19%
Change (1 day)
1.26%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Quarterly Reports

Annual ReportsQuarterly ReportsAnnual Reports (10-K)Quarterly Reports (10-Q)
Thumbnail Neurocrine Biosciences Quarterly Report 2026-q2

Quarterly Report 2026-q2

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences Quarterly Report 2026-q1

Quarterly Report 2026-q1

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences Quarterly Report 2025-q3

Quarterly Report 2025-q3

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences Quarterly Report 2025-q2

Quarterly Report 2025-q2

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences Quarterly Report 2025-q1

Quarterly Report 2025-q1

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences Quarterly Report 2024-q3

Quarterly Report 2024-q3

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences Quarterly Report 2024-q2

Quarterly Report 2024-q2

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences Quarterly Report 2024-q1

Quarterly Report 2024-q1

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences Quarterly Report 2023-q3

Quarterly Report 2023-q3

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences Quarterly Report 2023-q2

Quarterly Report 2023-q2

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences Quarterly Report 2023-q1

Quarterly Report 2023-q1

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences Quarterly Report 2022-q3

Quarterly Report 2022-q3

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences Quarterly Report 2022-q2

Quarterly Report 2022-q2

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences Quarterly Report 2022-q1

Quarterly Report 2022-q1

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences Quarterly Report 2021-q3

Quarterly Report 2021-q3

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences Quarterly Report 2021-q2

Quarterly Report 2021-q2

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences Quarterly Report 2021-q1

Quarterly Report 2021-q1

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences Quarterly Report 2020-q3

Quarterly Report 2020-q3

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences Quarterly Report 2020-q2

Quarterly Report 2020-q2

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences Quarterly Report 2020-q1

Quarterly Report 2020-q1

Language: English

View Quarterly Report

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com